JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 13, 2006; DOI: 10.1124/jpet.106.108209


0022-3565/06/3191-422-430$20.00
JPET 319:422-430, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108209v1
319/1/422    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarrete, C.
Right arrow Articles by Muñoz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarrete, C.
Right arrow Articles by Muñoz, E.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Basiliolides, a Class of Tetracyclic C19 Dilactones from Thapsia garganica, Release Ca2+ from the Endoplasmic Reticulum and Regulate the Activity of the Transcription Factors Nuclear Factor of Activated T Cells, Nuclear Factor-{kappa}B, and Activator Protein 1 in T Lymphocytes

Carmen Navarrete, Rocío Sancho, Francisco J. Caballero, Federica Pollastro, Bernd L. Fiebich, Olov Sterner, Giovanni Appendino, and Eduardo Muñoz

Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Córdoba, Spain (C.N., R.S., F.J.C., E.M.); Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, Università del Piemonte Orientale, Novara, Italy (F.P., G.A.); Vivacell Biotechnology GmbH, Denzlingen, Germany (B.L.F.); and Department of Organic Chemistry, Lund University, Lund, Sweden (O.S.)

Received May 20, 2006; accepted July 12, 2006.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Calcium concentration within the endoplasmic reticulum (ER) plays an essential role in cell physiology. We have investigated the effects of basiliolides, a novel class of C19 dilactones isolated from Thapsia garganica, on Ca2+ mobilization in T cells. Basiliolide A1 induced a rapid mobilization of intracellular Ca2+ in the leukemia T-cell line Jurkat. First, a rapid calcium peak was observed and inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester. This initial calcium mobilization was followed by a sustained elevation, mediated by the entry of extracellular calcium through store-operated calcium release-activated Ca2+ (CRAC) channels and sensitive to inhibition by EGTA, and by the CRAC channel inhibitor N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide (BTP-2). Basiliolide A1 mobilized Ca2+ from ER stores, but in contrast to thapsigargin, it did not induce apoptosis. Basiliolide A1 induced nuclear factor of activated T cells 1 dephosphorylation and activation that was inhibited by BTP-2 and cyclosporine A. In addition, we found that basiliolide A1 alone did not mediate I{kappa}B{alpha} degradation or RelA phosphorylation (ser536), but it synergized with phorbol 12-myristate 13-acetate to induce a complete degradation of the nuclear factor-{kappa}B inhibitory protein and to activate the c-Jun NH2-terminal kinase. Moreover, basiliolide A1 regulated both interleukin-2 and tumor necrosis factor-{alpha} gene expression at the transcriptional level. In basiliolide B, oxidation of one of the two geminal methyls to a carboxymethyl group retained most of the activity of basiliolide A1. In contrast, basiliolide C, where the 15-carbon is oxidized to an acetoxymethine, was much less active. These findings qualify these compounds as new probes to investigate intracellular calcium homeostasis.


The sesquiterpene lactone thapsigargin (TG) is an irreversible inhibitor of sarco(endo)plasmic reticulum Ca2+ ATPases (SERCAs) and has become an indispensable tool to study calcium homeostasis (Treiman et al., 1998Go). TG causes a net transfer of Ca2+ from the endoplasmic reticulum (ER) to cytosol, elevating [Ca2+]i (Thastrup et al., 1990Go; Rooney and Meldolesi, 1996Go) and inducing apoptosis via ER stress. We have recently shown that, apart from TG, T. garganica also contains compounds capable of mobilizing Ca2+ from the ER. These were identified in a series of unique C19 dilactones named basiliolides (Appendino et al., 2005Go).

In biological systems, calcium ions (Ca2+) function as ubiquitous messengers that play an essential role in signal transduction and control a wide array of cellular functions. In T cells, the signal transduction pathways triggered by the activation of the T-cell receptor (TCR)/CD3 complex lead to the immediate activation of transcription factors that regulate a variety of activation-associated genes. Many of them are cytokines and surface receptors that play an important role in coordinating the immune response (Crabtree and Clipstone, 1994Go). The signal transduction pathways involved in T-cell activation are initiated by the activation of phospholipase C{gamma} by specific tyrosine kinases at the lipid rafts, resulting in the hydrolysis of phosphatidylinositol-4,5-bisphosphate and generation of inositol-(1,4,5)-triphosphate (InsP3) and diacylglycerol. InsP3 binds to the InsP3 receptor (InsP3R) in the membrane of the ER, which is the main intracellular Ca2+ store, and initiates release of the stored Ca2+. Depletion of the ER of Ca2+ activates store-operated calcium release-activated Ca2+ (CRAC) channels in the plasma membrane that is an essential step during T-lymphocyte activation (Lewis, 2001Go). The Ca2+ influx operated through these channels is critical to induce an effective immune response (Feske et al., 2001Go).

Nuclear factor of activated T cells (NFAT) is a family of transcription factors present in cells and tissues both inside and outside of the immune system and is composed of at least four structurally related members, NFAT1, NFAT2, NFAT3, and NFAT4, that are expressed in the cytoplasm of the resting cells as well as the constitutively nuclear NFAT5 member (Hogan et al., 2003Go). As a consequence of an increase of [Ca2+]i levels, calcineurin is activated. This Ca2+-calmodulin-dependent protein phosphatase subsequently dephosphorylates the NFAT, triggering its nuclear shuttling. Once in the nucleus, NFAT binds to the DNA either alone or in conjunction with other transcriptional partners (Macian, 2005Go). The activator protein 1 (AP-1) is considered the major interacting partner of NFAT and is also controlled by TCR-dependent Ca2+ signals through Ca2+-dependent kinases (Rao et al., 1997Go). NFAT was first described as an inducible regulatory complex critical for transcriptional induction of IL-2 gene in activated T cells (Shaw et al., 1988Go) but was subsequently shown to regulate the transcription of many other cytokines and T-cell activation-induced proteins (Macian, 2005Go).

The transcription factor nuclear factor-{kappa}B (NF-{kappa}B) is one of the key regulators of genes involved in the immune/inflammatory response as well as in survival from apoptosis. NF-{kappa}B is an inducible transcription factor that interacts with a family of inhibitory I{kappa}B proteins, of which I{kappa}B{alpha} is the best characterized (Karin and Ben-Neriah, 2000Go). In most cell types, these proteins sequester NF-{kappa}B in the cytoplasm by masking its nuclear localization sequence. Antigen stimulation in T cells triggers a signaling pathway that results in the phosphorylation, ubiquitination, and subsequent degradation of I{kappa}B proteins, with the eventual translocation of NF-{kappa}B from the cytoplasm to the nucleus (Karin and Ben-Neriah, 2000Go). Although the signaling pathways leading to NF-{kappa}B activation downstream to TCR engagement are not fully understood, it has been shown that NF-{kappa}B activity is also influenced by a rise in [Ca2+]i (Feng et al., 2002Go).

Since basiliolides are structurally unrelated to TG, it was interesting to further investigate their biological profile and compare it with that of TG. We now report that basiliolides mobilize Ca2+ from the ER with a mechanism apparently different from that of TG, which qualifies these compounds as new probes to investigate intracellular calcium homeostasis.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Cell Lines and Reagents. Jurkat cells (American Type Culture Collection, Manassas, VA) were maintained in exponential growth in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 1 mM HEPES, and the antibiotics penicillin (100 U/ml) and streptomycin (100 µg/ml) (Invitrogen, Carlsbad, CA). Cells were maintained in a humid chamber at 37°C under 5% CO2. The anti-I{kappa}B{alpha} mAb was a gift from R. T. Hay (Centre for Biomolecular Sciences, University of St. Andrews, St. Andrews, Scotland), and the rabbit polyclonal anti-NFAT1 was a gift from J. M. Redondo (Centro de Bioquimica y Biologia Molecular, Madrid, Spain). The anti-phospho-ERK1 + 2 (sc-7383) was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and the mAbs anti-phospho-JNK (9255S) and anti-phospho-p65 (3031S) were from New England Biolabs (Hitchin, UK). Thapsigargin and the tetracyclic C19 dilactones basiliolide A1, B, and C were isolated from Thapsia garganica as described previously (Appendino et al., 2005Go). BTP-2 was from Calbiochem (San Diego, CA). All other reagents were from Sigma-Aldrich (St. Louis, MO).

Measurement of TNF-{alpha} Synthesis. Jurkat cells (106/ml) were treated as indicated for 6 h in complete medium. After culture, supernatants were harvested and centrifuged for 10 min at 10,000g, and the levels of TNF-{alpha} in the supernatant were measured by enzyme-linked immunosorbent assay (Immunotools, Friesoythe, Germany) according to the manufacturer's instructions. Experiments were carried out in triplicate. Analysis was performed using analysis of variance followed by the Student-Newman-Keuls method with values of p < 0.05 considered to be significant.

Cell Cycle Analysis and Cytotoxicity Assays. The percentage of cells in each phase of the cell cycle was determined by flow cytometry. In brief, cells were collected after treatments, washed twice with phosphate-buffered saline (PBS), and fixed with 70% ethanol for 24 h at 4°C. The cells were then washed twice with PBS solution and subjected to RNA digestion (50 U/ml RNase-A) and 20 µg/ml propidium iodide staining in PBS for 1 h at room temperature. The cells were analyzed by cytofluorimetry. Under these conditions, low-molecular-weight DNA leaks from the ethanol-fixed cells, and the subsequent staining allows the determination of the percentage of apoptotic cells (sub-G0/G1 fraction). For cytotoxicity analysis, Jurkat cells were seeded in 96-well plates in complete medium and treated with increasing doses of either thapsigargin or basiliolide A1 for the indicated times. Samples were then diluted with 300 µl of PBS and incubated for 1 min at room temperature in the presence of 10 µg/ml propidium iodide. After incubation, cells were immediately analyzed by flow cytometry.

Ca2+ Mobilization Assay in Jurkat Cells. Jurkat cells were incubated for 1 h at 37°C in Tyrode's salt solution (137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 0.4 mM NaH2PO4, 12.0 mM NaHCO3, and 5.6 mM D-glucose) containing 5 µM Indo1-AM (Invitrogen) for 30 min at 37°C in the dark. Cells were then harvested, washed three times with buffer to remove extracellular Indo1 dye, readjusted to 106 cells/ml in the appropriate buffer, and analyzed in a spectrofluorimeter operated in the ratio mode (model F-2500; Hitachi Ltd., Tokyo, Japan) under continuous stirring and at a constant temperature of 37°C using a water-jacketed device. After 5-min accommodation to equilibrate temperatures, samples were excited at 338 nm, and emission was collected at 405 and 485 nm, corresponding to the fluorescence emitted by Ca2+-bound and -free Indo1, respectively. [Ca2+]i was calculated using the ratio values between bound and free Indo1 fluorescence and assuming an Indo1 Kd for Ca2+ of 0.23 µM. Maximal and minimal ratio values for calculations were determined by the addition at the end of the measurements of 10 µM ionomycin or 4 mM EGTA, respectively. [Ca2+]i changes are presented as changes in the ratio of bound to free calcium (340 nm/380 nm). To determine the rate of Ca2+ entry, Indo1-loaded cells were suspended in nominally Ca2+-free buffer (50 mM HEPES, pH 7.5, and 200 mM NaCl) and stimulated with basiliolide A as indicated. Then, 1 mM CaCl2 was introduced in the medium, and the ensuing increase in [Ca2+]i was monitored.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1. Effect of basiliolide A1 on calcium mobilization. A and B, Jurkat cells were loaded with Indo1-AM, treated with increasing concentrations of either basiliolide (BSD) A1 or thapsigargin, or solvent alone (dimethyl sulfoxide), and the calcium mobilization was measured by ratiometric fluorescence as indicated under Materials and Methods. C and D, concentrations of BSD A1 and thapsigargin used were 5 and 1 µM, respectively. Vertical arrow indicates the time of compound addition. After 5-min recording, 1 µg/ml ionomycin was added to standardize results. [Ca2+]i changes are presented as changes in the ratio of bound to free calcium (340 nm/380 nm). The calcium traces are representative of at least five independent experiments.

 
Transient Transfections and Luciferase Activity. Jurkat cells (106) were transfected with the 100 ng of the reporter plasmids by using Lipofectamine reagent (Invitrogen) following the manufacturer's instructions. Twenty-four hours after transfection, the cells were stimulated as indicated for 6 h and then lysed in 25 mM Tris-phosphate, pH 7.8, 8 mM MgCl2, 1 mM dithiothreitol, 1% Triton X-100, and 7% glycerol. Luciferase activity was measured using an Autolumat LB 9501 (Berthold Technologies, Bad Wildbad, Germany) following the instructions of the luciferase assay kit (Promega, Madison, WI), and protein concentration was measured by the Bradford method (Bradford, 1976Go). The background obtained with the lysis buffer was subtracted in each experimental value, and the specific transactivation was expressed as total relative light unit (RLU) induction. All the experiments were repeated at least three times. Analysis was performed using analysis of variance followed by the Student-Newman-Keuls method with values of p < 0.05 considered to be significant. The AP-1-Luc, NFAT-Luc, KBF-Luc, IL-2-Luc, and TNF-Luc plasmids have been described previously (Sancho et al., 2004Go).

Western Blots. Jurkat cells (106 cells/ml) were stimulated as indicated and then washed with PBS and resuspended in lysis buffer (20 mM HEPES, pH 8.0, 0.35 M NaCl, 0.1 mM EGTA, 0.5 mM EDTA, 1 mM MgCl2, 20% glycerol, 1 mM dithiothreitol, 1 µg/ml leupeptin, 0.5 µg/ml pepstatin, 0.5 µg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride) containing 0.5% Nonidet P-40. Cells were incubated for 15 min at 4°C, and cellular proteins were obtained by centrifugation. Protein concentration was determined by Bradford assay (Bio-Rad, Hercules, CA), and 30 µg of proteins was boiled in Laemmli buffer and electrophoresed in 10% SDS-polyacrylamide gels or in 6% SDS-polyacrylamide gels (for NFAT detection). Separated proteins were transferred to nitrocellulose membranes (0.5 A at 100 V; 4°C) for 1 h. Blots were blocked in Tris-buffered saline solution containing 0.1% Tween 20 and 5% nonfat dry milk overnight at 4°C, and immunodetection of specific proteins was carried out with primary antibodies using an ECL system (GE Healthcare, Little Chalfont, Buckinghamshire, UK).


Figure 2
View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2. Effect of basililolide A1 on ER-induced Ca2+ release and CRAC channels. A, Jurkat cells were loaded with Indo1-AM as described in Fig. 1 and then incubated with either 5 µM BAPTA-AM, 2 mM EGTA for 30 min, or BTP-2 for 24 h before 5 µM basiliolide A1 treatment (vertical arrow). B, Indo-A-loaded Jurkat cells were incubated in nominally Ca2+-free buffer and treated or not with 5 µM BSD A1 at the indicated time followed by addition of 1 mM CaCl2. C, Jurkat T cells were preincubated during 24 h with the CRAC channel inhibitor BTP-2 (11.8 nM), and then the [Ca2+] measurement was performed as described in B. [Ca2+]i changes are presented as changes in the ratio of bound to free calcium (340 nm/380 nm). The calcium traces are representative of at least three independent experiments.

 

    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Effects of Basiliolide A1 on [Ca2+]i Mobilization. We have previously shown that basiliolides mobilize [Ca2+]i in sea urchin eggs (Appendino et al., 2005Go). To study the effects of these novel compounds in mammalian cells, the [Ca2+]i in Indo1-loaded Jurkat cells was analyzed. Addition of increasing concentrations of basiliolide A1 to the cells resulted in a rapid increase in [Ca2+]i comparable with the increase induced by TG (Fig. 1, A and B). The Ca2+ increase was maintained throughout the recording in response to both compounds, although TG was slightly more potent than basiliolide A1 (Fig. 1, A and B). When ER intracellular stores were depleted by thapsigargin, basiliolide A1 was no longer able to mobilize [Ca2+]i (Fig. 1C), but TG could still mobilize [Ca2+]i in basiliolide A1-treated cells (Fig. 1D). These observations suggest that thapsigargin and basiliolide A1 target the Ca2+ ER stores through different mechanisms.

The rapid and sustained effect of basiliolide A on [Ca2+]i mobilization suggests the participation of CRAC in such mobilization. To dissect the biochemical mechanism for this basiliolide A-induced calcium mobilization, we examined the effects of EGTA, an extracellular calcium chelator, and BAPTA-AM, a compound that can enter cells in an ester form, but that is then hydrolyzed by intracellular esterases and retained in the cytoplasm, acting as a specific calcium chelator. A different pattern of basililoide A-induced calcium mobilization was observed in the presence of either EGTA or BAPTA-AM (Fig. 2A). When cells were treated with BAPTA-AM, the early elevation of intracellular calcium disappeared, but a slow calcium accumulation persisted. On the contrary, cells treated with EGTA, which cannot enter the cell, showed the rapid and early phase of calcium mobilization in response to basiliolide A, but it disappeared within seconds until it reached the basal levels. These data indicate that basiliolide A induces calcium mobilization by at least two coupled mechanisms. The first mechanism would be mediated by the release of calcium from intracellular stores (inhibited by BAPTA-AM), and the second mechanism would be mediated by the entry of extracellular calcium, inhibited by EGTA and probably induced by the opening of cell surface calcium channels. The effects of BAPTA as calcium chelator may be sufficient to quench a limited amount of the calcium release to the cytosol (internal stores), but it is not able to quench completely the high [Ca2+]i induced by basiliolide A in Jurkat cells. Next, we reasoned that basiliolide A1-induced Ca2+ depletion of the ER should activate CRAC channels in the plasma membrane and to address this point, we preincubated the cells for 24 h with the potent CRAC channel inhibitor BTP-2 (Zitt et al., 2004Go). We found that basiliolide A1 induced the early phase of calcium mobilization, but the late phase was completely prevented by BTP-2 (Fig. 2A). To further confirm the activity of basiliolide A1 on calcium mobilization from ER stores and CRAC channels, we performed experiments in nominally free calcium, and we observed that basiliolide A induces an immediate [Ca2+]i mobilization that was further enhanced by the addition of CaCl2 to the cuvette (Fig. 2B). As expected, the [Ca2+]i increase mediated by the addition of CaCl2 was almost completely inhibited by preincubation of the cells with BTP-2 (Fig. 2C), but not by the L-type calcium channels blockers verapamil and nifedipine (data not shown).


Figure 3
View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3. A, basiliolide A1 does not induce apoptosis in Jurkat cells. Jurkat T cells were incubated with 5 µM BSD A1, 1 µM thapsigargin, or the calcium ionophore ionomycin (1 µM) for 18 h. After treatments, cells were harvested, and the percentage of cell in each cell cycle phase was determined by propidium iodide staining followed by flow cytometry analysis. The percentages of cells in sub-Go/Gs phase of the cell cycle are indicated. B, effects of basiliolide A1 and TG on cell viability. Jurkat cells were treated with increasing concentrations of either basiliolide A1 or TG for 6, 12, and 18 h. After treatments, cells were harvested, and the percentage of cell death was determined by propidium iodide staining followed by flow cytometry analysis. Results are represented as the percentage of cell viability and are the mean ± S.D. of three different experiments.

 
Basiliolide A1 Does Not Induce Apoptosis in Jurkat Cells. It has been shown that depletion of intracellular [Ca2+]i store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in a variety of mammalian cells (Jiang et al., 1994Go; Kaneko and Tsukamoto, 1994Go). Since basiliolide A also depletes ER intracellular [Ca2+]i stores in Jurkat cells, we investigated its potential proapoptotic activity. The cells were incubated with 5 µM basiliolide A, 1 µM thapsigargin, or the calcium ionophore ionomycin (1 µM) for 18 h, and the hypodiploidy (i.e., loss of fragmented DNA) was detected, using propidium iodide staining, as a marker for apoptosis. Figure 3A shows that both thapsigargin and ionomycin were able to induce a clear increase in the percentage of hypodiploid cells (57.9 and 23.5%, respectively). In contrast, basiliolide A1 lacked apoptotic activity, indicating that this compound does not induce the ER stress required to activate the apoptotic program (Lang et al., 2005Go). The rise of [Ca2+]i is also involved in the necrotic pathway of cell death that cannot be measured by cell cycle analysis; therefore, we sought to study the effects of basiliolide A1 and TG on cellular toxicity that was evaluated by propidium iodide staining and flow cytometry. Jurkat cells were treated with increasing doses of both compounds, and cell viability was tested after 6, 12, and 18 h. As depicted in Fig. 3B, basiliolide A1 lacked cytotoxic effects at the concentrations and times analyzed. In contrast, TG clearly induced cell death with all the concentration tested.


Figure 4
View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4. Effect of basiliolide A1 on NFAT activation. A, Jurkat cells transiently transfected with NFAT-Luc reporter plasmid were treated with the indicated doses of basiliolide A1 and PMA (50 ng/ml) for 6 h, and luciferase activity was measured in the cell lysates. Results are the mean ± S.E. of three determinations expressed as -fold induction (experimental RLU - background RLU/basal RLU - background RLU). *, p < 0.05 and **, p < 0.01 compared with PMA treatment. B, Jurkat cells were stimulated with 1 µM BSD A1, 50 ng/ml PMA, and 1 µM ionomycin as indicated, and the phosphorylation status of NFAT was detected in the cellular extracts. C, NFAT-Luc-transfected Jurkat cells were pretreated or not with either BTP-2 or dantrolene followed by stimulation or not with 1 µM ionomycin, 50 ng/ml PMA plus 1 µM BSD A1 for 6 h as shown the figure. Results are the mean ± S.E. of three determinations expressed as -fold induction. Inset, Jurkat cells preincubated (1) or not (2) with BTP-2 for 24 h and then treated with 1 µM BSD A1 for 30 min and NFAT1, detected by Western blot.

 
Effects of Basiliolide A1 on NFAT Activation. Transcriptional activation of NFAT requires its translocation to the nucleus where it binds to specific consensus sites in the promoter region of the target genes. Since NFAT activation is tightly regulated by [Ca2+]i mobilization, we studied the role of basiliolide A on NFAT transactivation activity. Jurkat cells were transfected with a luciferase reporter construct under the control of minimal promoter containing three NFAT binding sites, and 24 h later, the cells were stimulated for 6 h with PMA alone or in the presence of increasing concentrations of basiliolide A or thapsigargin. The results (Fig. 4A) demonstrated that basiliode A effectively induces the luciferase expression driven by the artificial NFAT promoter in PMA-stimulated cells and in a concentration-dependent manner. As expected, neither basiliolide A nor PMA was able to induce NFAT-dependent luciferase activity. Next, we examined NFAT1 expression and phosphorylation in basiliolide A-stimulated Jurkat cells by immunoblots of total extracts with a polyclonal anti-NFAT1 antiserum. Similarly to ionomycin, the stimulation of cells with basiliolide A alone or in combination with PMA for 30 min caused a marked NFAT dephosphorylation that was prevented by preincubation with cyclosporin A (Fig. 4B). According to our previous results with the [Ca2+]i measurements (Fig. 2, B and C), BTP-2 inhibited the basiliolide A-induced NFAT dephosphorylation and transcriptional activity (Fig. 4C, inset). In contrast, dantrolene, an inhibitor of ER ryanodine receptor, did not modify the NFAT transactivation activity (Fig. 4C).


Figure 5
View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5. Effect of basiliolide A1 on the mitogen-activated protein kinase and the NF-{kappa}B activation pathways. A, Jurkat cells were treated with 1 µM BSD A1, 1 µM ionomycin, or 50 ng/ml PMA as indicated, and the steady-state levels of I{kappa}B{alpha} and the phosphorylation status of p65 (ser536), JNK, and ERK were analyzed by Western blot using specific mAbs. BSD A1 regulates NF-{kappa}B and AP-1 transcriptional activities. Jurkat T cells were transiently transfected with the luciferase reporter plasmids KBF-Luc (B) and AP-1-Luc (C), as described under Materials and Methods. Cells were stimulated with 1 µM BSD A1, 50 ng/ml PMA, or 1 µM ionomycin for 6 h, and the luciferase activity measured. The results are the mean ± S.E. of three determinations and are expressed as RLUs.

 
Effects of Basiliolide A1 in the Signaling Pathways Leading to NF-{kappa}B and AP-1 Activation. Whereas [Ca2+]i is clearly involved in NFAT dephosphorylation and nuclear translocation, its effect on NF-{kappa}B and AP-1 activation is more indirect (Rao et al., 1997Go). However, ER stress induced by thapsigargin has been shown to activate the NF-{kappa}B and mitogen-activated protein kinase signaling pathway (Maloney et al., 1999Go; Rosado and Sage, 2001Go; Engedal et al., 2002Go; Leonardi et al., 2002Go). Thus, we investigated some of major biochemical pathways activated by basiliolide A leading to NF-{kappa}B and AP-1 activation in Jurkat cells. We found that basiliolide A1 alone did not induce I{kappa}B{alpha} degradation nor RelA (NF-{kappa}B subunit) phosphorylation (ser536), but it synergized with PMA to induce a complete degradation of this NF-{kappa}B inhibitory protein (Fig. 5A). We also detected that basiliolide A1 and ionomycin increased PMA-mediated JNK1 and JNK2 phosphorylation, whereas PMA-induced ERK1 and ERK2 phosphorylation was not affected (Fig. 5A). Accordingly, basiliolide A1 synergized with PMA to induce NF-{kappa}B- and AP-1-dependent transcriptional activation (Fig. 5, B and C).

IL-2 and TNF-{alpha} gene promoter are regulated by the coordinated action of NFAT, NF-{kappa}B, and AP-1 transcription factors that are activated by antigen receptor engagement plus an accessory signal usually supplied by the antigen-presenting cell (Crabtree and Clipstone, 1994Go). Agents that bypass these receptors, such as PMA and ionomycin, can mimic T-cell activation in the Jurkat cells. Thus, the costimulatory effect of basiliolide A1 was studied by transfecting Jurkat cells with the reporter plasmids IL-2-Luc and TNF-{alpha}-Luc. After transfection, cells were treated with PMA alone or in combination with basiliolide A1 or ionomycin as a control for 6 h and tested for luciferase activity. In Fig. 6, it is shown that basiliolide A1 is a potent coactivator with PMA to induce the luciferase expression driven by both calcium-dependent cellular gene promoters (Fig. 6, A and B). Interestingly, basiliolide A1 was more effective than ionomycin to induce TNF-{alpha} release from the cells (Fig. 6C), suggesting that basiliolide A1 may control the release of cytokines at both transcriptional and post-transcriptional levels.


Figure 6
View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6. Effect of basiliolide A1 on IL-2 and TNF-{alpha} gene promoter activity and TNF-{alpha} release. Jurkat T cells were transfected with either the IL-2 promoter luciferase reporter plasmid (A) or the TNF-{alpha} promoter luciferase reporter plasmid (B), and 24 h later they were stimulated for 6 h with 1 µM BSD A1, 1 µM ionomycin, or 50 ng/ml PMA as indicated, and luciferase activity was measured in the cell lysates. Results are the mean ± S.E. of three determinations expressed as -fold induction (experimental RLU - background RLU/basal RLU - background RLU). C, Jurkat cells were stimulated for 6 h with 1 µM BSD A1, 1 µM ionomycin, or 50 ng/ml PMA, and the TNF-{alpha} release was measured in the supernatants by enzyme-linked immunosorbent assay. The results are the mean ± S.E. of three determinations. *, p < 0.01 compared with PMA treatment and **, p < 0.01 compared with PMA plus ionomycin treatment.

 

The Position 15 of Basiliolide Structure Is Critical for NFAT Activation in Jurkat Cells. To gain insight on the structure-activity relationships of basiliolides, the activity of basiliolide A1 was compared with that of its two more oxidized analogs, basiliolides B and C (Fig. 7). Although basiliolide B, differing in the oxidation of one of the two geminal methyls to a carboxymethyl group retained most of the activity of basiliolide A1, basiliolide C, where the 15-carbon is oxidized to an acetoxymethine, was much less active. In contrast to basiliolide A, high concentrations of thapsigargin were less effective than lower concentrations to induce NFAT-dependent luciferase activity.


Figure 7
View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7. Critical role of the position 15 in the biological activity of basiliolide A1. Chemical structures of BSD A1 compared with that of its two oxidized analogs, BSD-B and BSD-C (top). Jurkat cells transiently transfected with the NFAT-Luc reporter plasmid were treated with 50 ng/ml PMA alone or in combination with either 1 µM ionomycin, BSD A1, BSD B, BSD C, or TG for 6 h, and the luciferase activity was measured and expressed as -fold induction. Results are the mean ± S.E. of three determinations.

 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Control of cytosolic Ca2+ levels involves the coordination of diverse intracellular and extracellular Ca2+ currents and plays a critical role in a wide range of cellular functions, including apoptosis. We show here that basiliolide A1 increases cytosolic [Ca2+] by inducing Ca2+i transfer from ER to cytosol and eventual activation of CRAC channels. The sustained [Ca2+]i elevation in basiliolide A1-treated Jurkat cells is sufficient to activate gene expression but not to induce apoptosis. Conversely, both the calcium ionophore ionomycin and the irreversible SERCA inhibitor thapsigargin were able to induce apoptosis in these cells, suggesting that basilioide A1 mobilizes intracellular Ca2+ trough a different mechanism.

Under physiological conditions, Ca2+ release from ER to cytosol can be induced in T cells by the direct binding of the second messengers InsP3 and cyclic adenosine diphosphoribose via the InsP3R and the ryanodine receptor (RyR), respectively (Quintana et al., 2005Go). Basiliolide A1 might interfere with upstream mechanisms that lead to the generation of some of these second messengers. However, basiliolide A1 could induce calcium mobilization both in the parental Jurkat clone and in a phospholipase C{gamma}1-defficient line (Irvin et al., 2000Go; data not shown), whereas the RyR antagonist dantrolene was unable to prevent both [Ca2+]i elevation and NFAT activation induced by basiliolide. These observations rule out a direct activation of these ER receptors by basiliolide A1, suggesting an indirect interaction with them. Notwithstanding, at present we cannot discard the possibility that basiliolide A interacts directly either with InsP3R or RyR. It has been shown recently that Homer, a scaffold protein, physically associates with the ryanodine receptors type 1, regulating gating responses to Ca2+ and caffeine (Feng et al., 2002Go) as well as NFAT-dependent signaling (Stiber et al., 2005Go). It is therefore not inconceivable that, just like caffeine, basiliolide A1 also modulates RyR in a Homer-dependent manner (Feng et al., 2002Go).

SERCA is a critical enzyme that pumps Ca2+ from the cytosol into the ER lumen to maintain a low [Ca2+]i. The sustained inhibition of this activity causes depletion of intracellular Ca2+ stores and activation of capacitative Ca2+ entry, generating supramolecular [Ca2+]i in the cytosol. In Jurkat and related cell types, this activates apoptotic pathways (Jayaraman and Marks, 1997Go). The very tight binding of thapsigargin to all currently known SERCAs causes an irreversible inhibition that persists after removal of the excess inhibitor (Waldron et al., 1994Go), an observation that can explain, or contribute to, the potent apoptotic activity of this compound. Conversely, basiliolide A1 was unable to induce apoptosis in Jurkat cells, despite its alleged SERCA inhibitory activity (Appendino et al., 2005Go). It is therefore tempting to suggest that basiliolide A1 acts as a reversible SERCA inhibitor, not unlike 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a SERCA blocker that protects HeLa cells from ceramide-induced apoptosis (Pinton et al., 2001Go). The reversible activity of basiliolide A1 is supported by the observation that Jurkat cells treated with this compound for 1 h and then washed and cultured again for 12 h in calcium-containing medium were still sensible to the [Ca2+]-mobilizing properties of basiliolide A1 (data not shown). To conciliate these observations, we can assume that the reduction of the ER [Ca2+]i by basiliolide A1 leads to a constant release of Ca2+ to the cytosol and reuptake by the ER, whose long kinetics makes it possible for calcium to equilibrate between different intracellular organelles. This calcium leakage can be translated into calcium-dependent gene transcription and other cellular functions but not into the induction of cell death. Thapsigargin and ionomycin generate instead very high [Ca2+]i and quickly induce apoptosis. We are currently investigating whether basiliolide A1 can protect cells from ceramide-induced apoptosis in T cells and in other cell types. Another interesting difference between basiliolide A1 and thapsigargin is that NFAT activation by thapsigargin has a complex kinetics, with high concentrations being less efficient than lower concentrations. This could be explained in part by an increase in apoptosis, since a higher percentage of cell death was found in Jurkat cells treated with 5 µM TG compared with cells treated with lower concentrations of this SERCA inhibitor. Interestingly, it has been proposed that high concentrations of thapsigargin can also have inhibitory effect on Ca2+ or Mn2+ entry from the medium (Mason et al., 1991Go). Taken together, these observations qualify basiliolides as a novel class of molecular probes to study calcium homeostasis, characterized by lack of apoptotic and CRAC inhibitory activity.

NFAT, NF-{kappa}B, and AP-1 are probably the three most important transcription factor families in T cells, all of them being activated downstream from TCR engagement in a Ca2+-dependent manner. Whereas [Ca2+]i is clearly involved in activation of NFAT, the role of [Ca2+]i may be regarded as being more indirect for NF-{kappa}B and AP-1 (Feske et al., 2001Go; Li and Verma, 2002Go). Accordingly, we found that basiliolide A1 is potent costimulator of the NF-{kappa}B and the AP-1 pathways in T cells, but this activity was not restricted to T cells, since we observed that basiliolides also regulates NFAT and NF-{kappa}B activity in neuronal cells (our unpublished data). This is of special relevance, since both transcription factors can protect neurons from cell death both "in vivo" and "in vitro" (Fridmacher et al., 2003Go; Benedito et al., 2005Go). Noncytotoxic compounds that mobilize calcium by targeting the ER are currently of great interest for the treatment of neurodegenerative diseases

The differences between the activity of basiliolides A1, B, and C demonstrate the existence of definite structure-activity relationships within these compounds and should spur activity aimed at the isolation of further members of this class of compounds and/or to their semisynthetic modification. As a final observation, it is interesting to remark that T. garganica is one of the oldest medicinal plants, and it is therefore surprising that this treasure trove of bioactive compounds was overlooked for so long in terms of phytochemical and pharmacological investigations.


    Acknowledgements
 
We thank Dr. Juan M. Redondo for the anti-NFAT1 antisera.


    Footnotes
 
This work was supported by Ministerio de Educación y Ciencia Grant SAF2004-00926 (to E.M.).

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.106.108209.

ABBREVIATIONS: TG, thapsigargin; SERCA, sarco(endo)plasmic reticulum Ca2+ ATPase; ER, endoplasmic reticulum; TCR, T-cell receptor; InsP3, inositol-(1,4,5)-triphosphate; InsP3R, inositol-(1,4,5)-triphosphate receptor; CRAC, calcium release-activated Ca2+ channel; NFAT, nuclear factor of activated T cells; AP-1, activator protein-1; IL, interleukin; NF-{kappa}B, nuclear factor-{kappa}B; mAb, monoclonal antibody; ERK, extracellular regulated kinase; JNK, c-Jun NH2-terminal kinase; BTP-2, N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide; TNF, tumor necrosis factor; PBS, phosphate-buffered saline; AM, acetoxymethyl ester, RLU, relative light unit; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; PMA, phorbol 12-myristate 13-acetate; RyR, ryanodine receptor; BSD, basiliolide.

Address correspondence to: Dr. Eduardo Muñoz, Departamento de Biología Celular, Fisiología e Inmunología, Facultad de Medicina, Avda. de Menéndez Pidal s/n, Universidad de Córdoba, 14004 Córdoba, Spain. E-mail: fi1muble{at}uco.es


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Appendino G, Prosperini S, Valdivia C, Ballero M, Colombano G, Billington RA, Genazzani AA, and Sterner O (2005) SERCA-inhibiting activity of C-19 terpenolides from Thapsia garganica and their possible biogenesis. J Nat Prod 68: 1213-1217.[CrossRef][Medline]

Benedito AB, Lehtinen M, Massol R, Lopes UG, Kirchhausen T, Rao A, and Bonni A (2005) The transcription factor NFAT3 mediates neuronal survival. J Biol Chem 280: 2818-2825.[Abstract/Free Full Text]

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.[CrossRef][Medline]

Crabtree GR and Clipstone NA (1994) Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63: 1045-1083.[CrossRef][Medline]

Engedal N, Korkmaz CG, and Saatcioglu F (2002) c-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene 21: 1017-1027.[CrossRef][Medline]

Feng W, Tu J, Yang T, Vernon PS, Allen PD, Worley PF, and Pessah IN (2002) Homer regulates gain of ryanodine receptor type 1 channel complex. J Biol Chem 277: 44722-44730.[Abstract/Free Full Text]

Feske S, Giltnane J, Dolmetsch R, Staudt LM, and Rao A (2001) Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2: 316-324.[CrossRef][Medline]

Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, Kaltschmidt C, Israel A, and Memet S (2003) Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci 23: 9403-9408.[Abstract/Free Full Text]

Hogan PG, Chen L, Nardone J, and Rao A (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232.[Free Full Text]

Irvin BJ, Williams BL, Nilson AE, Maynor HO, and Abraham RT (2000) Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell Biol 20: 9149-9161.[Abstract/Free Full Text]

Jayaraman T and Marks AR (1997) T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 17: 3005-3012.[Abstract]

Jiang S, Chow SC, Nicotera P, and Orrenius S (1994) Intracellular Ca2+ signals activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor thapsigargin. Exp Cell Res 212: 84-92.[CrossRef][Medline]

Kaneko Y and Tsukamoto A (1994) Thapsigargin-induced persistent intracellular calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett 79: 147-155.[CrossRef][Medline]

Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-{kappa}B activity. Annu Rev Immunol 18: 621-663.[CrossRef][Medline]

Lang F, Foller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A, and Huber SM (2005) Ion channels in cell proliferation and apoptotic cell death. J Membr Biol 205: 147-157.[CrossRef][Medline]

Leonardi A, Vito P, Mauro C, Pacifico F, Ulianich L, Consiglio E, Formisano S, and Di Jeso B (2002) Endoplasmic reticulum stress causes thyroglobulin retention in this organelle and triggers activation of nuclear factor-kappa B via tumor necrosis factor receptor-associated factor 2. Endocrinology 143: 2169-2177.[Abstract/Free Full Text]

Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19: 497-521.[CrossRef][Medline]

Li Q and Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.[CrossRef][Medline]

Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.[CrossRef][Medline]

Maloney JA, Tsygankova OM, Yang L, Li Q, Szot A, Baysal K, and Williamson JR (1999) Activation of ERK by Ca2+ store depletion in rat liver epithelial cells. Am J Physiol 276: 221-230.

Mason MJ, Garcia-Rodriguez C, and Grinstein S (1991) Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. J Biol Chem 266: 20856-20862.[Abstract/Free Full Text]

Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, and Rizzuto R (2001) The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO (Eur Mol Biol Organ) J 20: 2690-2701.[CrossRef][Medline]

Quintana A, Griesemer D, Schwarz EC, and Hoth M (2005) Calcium-dependent activation of T-lymphocytes. Pflueg Arch Eur J Physiol 450: 1-12.[CrossRef][Medline]

Rao A, Luo C, and Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747.[CrossRef][Medline]

Rooney E and Meldolesi J (1996) The endoplasmic reticulum in PC12 cells. Evidence for a mosaic of domains differently specialized in Ca2+ handling. J Biol Chem 271: 29304-29311.[Abstract/Free Full Text]

Rosado JA and Sage SO (2001) Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets. J Biol Chem 276: 15659-15665.[Abstract/Free Full Text]

Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, and Munoz E (2004) Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways. J Immunol 172: 2341-2351.[Abstract/Free Full Text]

Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, and Crabtree GR (1988) Identification of a putative regulator of early T cell activation genes. Science (Wash DC) 241: 202-205.[Abstract/Free Full Text]

Stiber JA, Tabatabaei N, Hawkins AF, Hawke T, Worley PF, Williams RS, and Rosenberg P (2005) Homer modulates NFAT-dependent signaling during muscle differentiation. Dev Biol 287: 213-224.[Medline]

Thastrup O, Cullen PJ, Drobak BK, Hanley MR, and Dawson AP (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 87: 2466-2470.[Abstract/Free Full Text]

Treiman M, Caspersen C, and Christensen SB (1998) A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci 19: 131-135.[CrossRef][Medline]

Waldron RT, Short AD, Meadows JJ, Ghosh TK, and Gill DL (1994) Endoplasmic reticulum calcium pump expression and control of cell growth. J Biol Chem 269: 11927-11933.[Abstract/Free Full Text]

Zitt C, Strauss B, Schwarz EC, Spaeth N, Rast G, Hatzelmann A, and Hoth M (2004) Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2. J Biol Chem 279: 12427-12437.[Abstract/Free Full Text]



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108209v1
319/1/422    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarrete, C.
Right arrow Articles by Muñoz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarrete, C.
Right arrow Articles by Muñoz, E.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition